⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5950782 | 1.00 | — | — | |
| SCHEMBL14470625 | 1.00 | — | — | |
| SCHEMBL10277056 | 0.86 | — | — | |
| SCHEMBL7990770 | 0.77 | POLB (0.41) | — | |
| SCHEMBL25381502 | 0.77 | MAPK1 (0.40) | — | |
| SCHEMBL25382850 | 0.77 | MAPK1 (0.40) | — | |
| SCHEMBL16808523 | 0.76 | — | — | |
| SCHEMBL13093541 | 0.76 | — | — | |
| SCHEMBL826310 | 0.76 | — | — | |
| SCHEMBL7986814 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110372642-B | Method for treating homoserine-based compounds | CJ第一制糖株式会社 | 2023-04-07 | — | — | CN | claimed |
| EP-3130586-B1 | PROCESS FOR TREATING HOMOSERINE-BASED COMPOUND | CJ CHEILJEDANG CORP (KR) | 2019-10-23 | — | — | EP | claimed |
| US-10100026-B2 | Process for treating homoserine-based compound | CJ CHEILJEDANG CORPORATION (KR) | 2018-10-16 | — | — | US | claimed |
| EP-3130586-A1 | PROCESS FOR TREATING HOMOSERINE-BASED COMPOUND | Cj Cheiljedang Corporation (KR) | 2017-02-15 | — | — | EP | claimed |
| US-20170037019-A1 | PROCESS FOR TREATING HOMOSERINE-BASED COMPOUND | CJ CHEILJEDANG CORPORATION (KR) | 2017-02-09 | — | — | US | claimed |
| US-20070003838-A1 | Energy device | HITACHI, LTD. (JP) | 2007-01-04 | — | — | US | claimed |
| EP-4581035-A1 | EXATECAN-DERIVED TOPOISOMERASE-1 INHIBITORS PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | Merck Sharp & Dohme LLC (US) | 2025-07-09 | — | — | EP | disclosed |
| US-20240417388-A1 | BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6 | CANCER RESEARCH TECH LTD (GB) | 2024-12-19 | — | — | US | disclosed |
| US-12110286-B2 | Benzimidazolone derived inhibitors of BCL6 | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-10-08 | — | — | US | disclosed |
| CN-118561812-A | Benzimidazolone-derived BCL6 inhibitors | 癌症研究科技有限公司 | 2024-08-30 | — | — | CN | disclosed |
| EP-3630291-B9 | BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6 | CANCER RESEARCH TECH LTD (GB) | 2024-05-29 | — | — | EP | disclosed |
| EP-4374858-A2 | BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6 | Cancer Research Technology Limited (GB) | 2024-05-29 | — | — | EP | disclosed |
| CN-111163839-B | Benzimidazolone-derived BCL6 inhibitors | 癌症研究科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-7189015-B2 | Method for replenishing development replenisher in automatic developing machine for photosensitive lithographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 2007-03-13 | — | — | US | disclosed |
| US-20070003838-A1 | Energy device | HITACHI, LTD. (JP) | 2007-01-04 | — | — | US | disclosed |
| US-20060134515-A1 | Energy device and various applications using the same | HITACHI, LTD. (JP) | 2006-06-22 | — | — | US | disclosed |
| US-20060124973-A1 | Energy storage device, module thereof and electric vehicle using the same | HITACHI, LTD. (JP) | 2006-06-15 | — | — | US | disclosed |
| US-20060111347-A1 | Substituted sulfones and methods of use | AMGEN INC. (US) | 2006-05-25 | — | — | US | disclosed |
| EP-0037327-A1 | Derivates of 3-formyl-4-methylpentanoic acid, their preparation and their use in the preparation of substituted 3-formyl-but-3-en-1-oic acid | ROUSSEL-UCLAF (FR) | 1981-10-07 | — | — | EP | disclosed |
| EP-0024241-A1 | Sulphonated compounds comprising a lactone ring and the preparation of cyclopropane derivatives therefrom | ROUSSEL-UCLAF (FR) | 1981-02-25 | — | — | EP | disclosed |